If you’ve seen messages on TV about smoking cessation, you’ve probably noticed that most contain a particular message, either implicitly or explicitly: serious attempts at smoking cessation should be attempted with drugs and/or professional help. This so-called “medicalization” of smoking cessation has become the norm, even though there is much evidence to support “cold turkey” or reducing-then-quitting methods—undertaken privately and without professional intervention—may be the most effective approaches. Is it possible, with all of the products and approaches on the market, that simply quitting is the best approach?
Recent professional reviews of smoking cessation studies has shown repeatedly that 60–75% of ex-smokers (successful quitters) stop smoking without help. Furthermore, most ex-smokers then report that quitting was easier than expected.
The lack of awareness about “just quitting” as the most effective and valid approach may come, at least in part, from the influence of pharmaceutical support of smoking cessation studies. Studies using drugs or other therapies to assist in cessation nearly always involve researchers who support a pharmaceutical manufacturing company producing smoking cessation products, such as Chantix or similar drugs. Studies that use not cessation therapies or products rarely involve researchers connected with pharmaceutical companies. Additionally, pharmaceutical company-supported studies tend toward higher success rates.
Researchers hope that these revelations will spread to the public, to let smokers hoping to quit know that reduction, will power, and cold turkey are not only viable options in their efforts to quit, but may even be the most effective.
It’s also worthy to note that certain smoking cessation drugs, including Chantix, have been linked to very serious side effects including suicidal behavior. Contact our Chantix Lawyers immediately if you have experience any serious side effects to this anti-smoking drug.